title: Rapid eye movement sleep behavior disorder and rapid eye movement sleep without atonia in narcolepsy.
abstract: Narcolepsy is a rare disabling hypersomnia disorder that may include cataplexy, sleep paralysis, hypnagogic hallucinations, and sleep-onset rapid eye movement (REM) periods, but also disrupted nighttime sleep by nocturnal awakenings, and REM sleep behavior disorder (RBD). RBD is characterized by dream-enacting behavior and impaired motor inhibition during REM sleep (REM sleep without atonia, RSWA). RBD is commonly associated with neurodegenerative disorders including Parkinsonisms, but is also reported in narcolepsy in up to 60% of patients. RBD in patients with narcolepsy is, however, a distinct phenotype with respect to other RBD patients and characterized also by absence of gender predominance, elementary rather than complex movements, less violent behavior and earlier age at onset of motor events, and strong association to narcolepsy with cataplexy/hypocretin deficiency. Patients with narcolepsy often present dissociated sleep features including RSWA, increased density of phasic chin EMG and frequent shift from REM to NREM sleep, with or without associated clinical RBD. Most patients with narcolepsy with cataplexy lack the hypocretin neurons in the lateral hypothalamus. Tonic and phasic motor activities in REM sleep and dream-enacting behavior are mostly reported in presence of cataplexy. Narcolepsy without cataplexy is a condition rarely associated with hypocretin deficiency. We proposed that hypocretin neurons are centrally involved in motor control during wakefulness and sleep in humans, and that hypocretin deficiency causes a functional defect in the motor control involved in the development of cataplexy during wakefulness and RBD/RSWA/phasic motor activity during REM sleep.
authors.affiliation: National Reference Network for orphan diseases (Narcolepsy, Idiopathic Hypersomnia, and Klein Levine syndrome), Montpellier, France. ydauvilliers@yahoo.fr
authors.forename: Yves
authors.initials: Y
authors.lastname: Dauvilliers
authors.forename: Poul
authors.initials: P
authors.lastname: Jennum
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Plazzi
mesh_terms: D000328:Adult; D004525:Efferent Pathways / Q000502:physiology; D005260:Female; D006801:Humans; D007026:Hypothalamic Area, Lateral / Q000502:physiology; D047908:Intracellular Signaling Peptides and Proteins / Q000172:deficiency / Q000502:physiology; D008297:Male; D009068:Movement / Q000502:physiology; D009290:Narcolepsy / Q000150:complications* / Q000503:physiopathology*; D009479:Neuropeptides / Q000172:deficiency / Q000502:physiology; D000068797:Orexins; D020187:REM Sleep Behavior Disorder / Q000150:complications* / Q000503:physiopathology*; D012895:Sleep, REM / Q000502:physiology*; D014851:Wakefulness / Q000502:physiology
chemical_list: D047908:Intracellular Signaling Peptides and Proteins; D009479:Neuropeptides; D000068797:Orexins